Literature DB >> 3108333

Analysis of latex agglutination test for Clostridium difficile toxin A (D-1) and differentiation between C difficile toxins A and B and latex reactive protein.

S P Borriello, F E Barclay, P J Reed, A R Welch, J D Brown, D W Burdon.   

Abstract

Virulent toxigenic and avirulent non-toxigenic strains of Clostridium difficile gave a positive result in the latex agglutination test (LAT) for C difficile toxin A (D-1). Similar concentrations of latex agglutinating antigen were produced by these strains in vivo. Positive reactions were also given by C sporogenes, proteolytic C botulinum Types A, B, and A/F, and Bacteroides assaccharolyticus. The latex agglutinating antigen was denatured by boiling for 10 minutes, but not by heating at 56 degrees C for 30 minutes. The reaction was abolished by incubation of test material with crude C difficile antitoxin but not with other clostridial antitoxins or specific antitoxin to C difficile toxin A. The latex agglutinating antigen present in C difficile eluted between 0.39% and 0.47% M sodium chloride, and that produced by the other clostridia, between 0.35% and 0.43% M sodium chloride by fast protein liquid chromatography. The latex agglutinating antigen of C difficile was neither cytotoxic nor mouse lethal and was distinct from toxin A and toxin B. In the analysis of faecal specimens from patients with diarrhoea the latex agglutination test correlated better with the presence of C difficile than with toxin B and detected both toxigenic and non-toxigenic strains. The latex agglutination test should only be used in the laboratory as an alternative to culture for C difficile and not as a method for the detection of C difficile toxins.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3108333      PMCID: PMC1141028          DOI: 10.1136/jcp.40.5.573

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  12 in total

1.  Enzyme immunoassays for detection of Clostridium difficile toxins A and B in fecal specimens.

Authors:  B E Laughon; R P Viscidi; S L Gdovin; R H Yolken; J G Bartlett
Journal:  J Infect Dis       Date:  1984-05       Impact factor: 5.226

2.  A new purification procedure for Clostridium difficile enterotoxin.

Authors:  B Rihn; J M Scheftel; R Girardot; H Monteil
Journal:  Biochem Biophys Res Commun       Date:  1984-11-14       Impact factor: 3.575

3.  Purification and characterization of toxins A and B of Clostridium difficile.

Authors:  N M Sullivan; S Pellett; T D Wilkins
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

4.  Faecal toxin and severity of antibiotic-associated pseudomembranous colitis.

Authors:  D W Burdon; R H George; G A Mogg; Y Arabi; H Thompson; M Johnson; J Alexander-Williams; M R Keighley
Journal:  J Clin Pathol       Date:  1981-05       Impact factor: 3.411

5.  Epidemiology of experimental enterocecitis due to Clostridium difficile.

Authors:  H E Larson; A B Price; S P Borriello
Journal:  J Infect Dis       Date:  1980-09       Impact factor: 5.226

6.  The use of CIE for the detection of Clostridium difficile toxin in stool filtrates: laboratory and clinical correlation.

Authors:  T A Kurzynski; G S Cembrowski; J L Kimball
Journal:  Am J Clin Pathol       Date:  1983-03       Impact factor: 2.493

7.  Protection of hamsters against Clostridium difficile ileocaecitis by prior colonisation with non-pathogenic strains.

Authors:  S P Borriello; F E Barclay
Journal:  J Med Microbiol       Date:  1985-06       Impact factor: 2.472

8.  Differential cytotoxic effects of toxins A and B isolated from Clostridium difficile.

Authors:  S W Rothman; J E Brown; A Diecidue; D A Foret
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

9.  Quantitation of Clostridium botulinum organisms and toxin in the feces of an infant with botulism.

Authors:  J C Paton; A J Lawrence; J I Manson
Journal:  J Clin Microbiol       Date:  1982-01       Impact factor: 5.948

10.  Latex agglutination test for detection of Clostridium difficile toxin in stool samples.

Authors:  M S Shahrabadi; L E Bryan; D Gaffney; S E Coderre; R Gordon; C H Pai
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

View more
  13 in total

1.  Evaluation of a commercial enzyme immunoassay kit for the detection of Clostridium difficile toxin A.

Authors:  S P Borriello; T Vale; J S Brazier; S Hyde; E Chippeck
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

2.  Evaluation of a new commercial Clostridium difficile toxin A enzyme immunoassay using diarrhoeal stools.

Authors:  M Delmée; T Mackey; A Hamitou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-03       Impact factor: 3.267

3.  Multicenter evaluation of a new enzyme immunoassay for detection of Clostridium difficile enterotoxin A.

Authors:  P C De Girolami; P A Hanff; K Eichelberger; L Longhi; H Teresa; J Pratt; A Cheng; J M Letourneau; G M Thorne
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

Review 4.  Clostridium difficile: its disease and toxins.

Authors:  D M Lyerly; H C Krivan; T D Wilkins
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

5.  Multicenter evaluation of four methods for Clostridium difficile detection: ImmunoCard C. difficile, cytotoxin assay, culture, and latex agglutination.

Authors:  J L Staneck; L S Weckbach; S D Allen; J A Siders; P H Gilligan; G Coppitt; J A Kraft; D H Willis
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

Review 6.  Clostridium difficile-associated diarrhea: current strategies for diagnosis and therapy.

Authors:  Munshi Moyenuddin; John C Williamson; Christopher A Ohl
Journal:  Curr Gastroenterol Rep       Date:  2002-08

Review 7.  Clostridium difficile: clinical disease and diagnosis.

Authors:  F C Knoop; M Owens; I C Crocker
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

8.  Comparison of the premier toxin A and B assay and the TOX A/B II assay for diagnosis of Clostridium difficile infection.

Authors:  Susan M Novak-Weekley; Michele H Hollingsworth
Journal:  Clin Vaccine Immunol       Date:  2008-01-02

9.  Evaluation of a commercial latex test for Clostridium difficile for reactivity with C. difficile and cross-reactions with other bacteria.

Authors:  B L Miles; J A Siders; S D Allen
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

10.  Comparison of four methods in the diagnosis of Clostridium difficile disease.

Authors:  A R Mattia; G V Doern; J Clark; J Holden; L Wu; M J Ferraro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-11       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.